Condensed Consolidated Statements of Income (Loss) - USD ($) shares in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue:
ACO REACH revenue	$ 124,040,000	$ 171,811,000
Investment income	926,000	203,000
Total revenue	215,787,000	245,095,000
Operating expenses:
Medical costs	160,894,000	196,874,000
Operating costs	48,673,000	66,761,000
Depreciation and amortization	3,559,000	4,562,000
Total operating expenses	213,126,000	268,197,000
Operating income (loss)	2,661,000	(23,102,000)
Interest expense	6,637,000	2,930,000
Warrant income	(2,649,000)	(2,072,000)
Gain on troubled debt restructuring	0	(30,311,000)
(Loss) Income from continuing operations before income taxes	(1,327,000)	6,351,000
Income tax expense	111,000	663,000
Net (loss) income from continuing operations	(1,438,000)	5,688,000
Loss from discontinued operations, net of tax (Note 14)	(9,410,000)	(9,865,000)
Net Loss	(10,848,000)	(4,177,000)
Net income from continuing operations attributable to noncontrolling interests	(891,000)	(11,737,000)
Net loss attributable to NeueHealth, Inc. common shareholders	$ (24,875,000)	$ (28,518,000)
Basic and diluted loss per share attributable to NeueHealth, Inc. common shareholders
Continuing operations, basic (in dollars per share)	$ (1.80)	$ (2.31)
Continuing operations, diluted (in dollars per share)	(1.80)	(2.31)
Discontinued operations, basic (in dollars per share)	(1.10)	(1.22)
Discontinued operations, diluted (in dollars per share)	(1.10)	(1.22)
Net loss per share attributable to common stockholders, basic (in dollars per share)	(2.90)	(3.53)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (2.90)	$ (3.53)
Basic weighted-average common shares outstanding (in shares)	8,570	8,079
Diluted weighted-average common shares outstanding (in shares)	8,570	8,079
Series A preferred stock dividend accrued
Operating expenses:
Series A and B preferred stock dividend accrued	$ (10,729,000)	$ (10,294,000)
Series B preferred stock dividend accrued
Operating expenses:
Series A and B preferred stock dividend accrued	(2,407,000)	(2,310,000)
Capitated revenue
Revenue:
Revenue:	80,987,000	61,466,000
Service revenue
Revenue:
Revenue:	$ 9,834,000	$ 11,615,000